BT launches life sciences R&D into cloud

Introduction of cloud services for pharmaceutical industry is set to increase productivity.

cloud computing

BT has launched a new cloud service aimed at supporting and accelerating research and development (R&D) activities in life sciences.

[Companies can potentially reduce research costs and accelerate time to market by collaborating with third parties in a secure and compliant environment.

The Life Sciences R&D is the first cloud service to foster industry-specific, collaborative R&D work, while also complying with its information security and industry regulatory and compliance requirements, according to BT.

The provider said it enable scientists in pharmaceutical, biotech, devices and diagnostics companies, as well as academia and government, to develop new drugs and other innovations, thanks to the availabilty of large-scale computing and management resources required.

Advertisement - Article continues below
Advertisement - Article continues below

Bas Burger, BT Global Services president of Global Commerce, stated that the pharmaceutical industry was facing extreme challenges, where patent-protected revenues are at risk and R&D productivity is declining, resulting in lower revenues, despite the continued rise in the cost of bringing new drugs to market.

"Now companies can potentially reduce research costs and accelerate time to market by collaborating with third parties in a secure and compliant environment, and bring innovative solutions to market faster through computer simulation and modeling," he said. "This aims [to help] them develop new products faster, with lower costs and increased revenues."

The new cloud will use various elements of BT's portfolio, but a partnership with molecular modeling and simulation software company Accelrys, will use its specialist scientific applications in the new R&D cloud and, in turn, offer the partner's customers on-demand infrastructure services.

BT's Assure portfolio will secure and segregate the new cloud platform by offering the ability to design data encryption, anonymisation, risk management and resilience into the applications it will run.

The platform will also offer BT One for global collaboration and unified communications capabilities, BT Connect for high-capacity secure networking to allow for private, hybrid and public clouds Interoperability, BT Advise's professional services to manage migration, orchestration and support, and Bioteam cloud design and consulting services.

BT added that the new platform will initially build on BT's On Demand Compute service, with a compliance wrap' to meet quality assurance requirements according to the GxP3 standard for qualification.

Advertisement - Article continues below

The new cloud service would specifically allow researchers and scientists to construct and orchestrate in silico' workflows, data pipelines and predictive simulations to identify new pharmaceutical targets and drug candidates, BT claimed.

Featured Resources

Digitally perfecting the supply chain

How new technologies are being leveraged to transform the manufacturing supply chain

Download now

Three keys to maximise application migration and modernisation success

Harness the benefits that modernised applications can offer

Download now

Your enterprise cloud solutions guide

Infrastructure designed to meet your company's IT needs for next-generation cloud applications

Download now

The 3 approaches of Breach and Attack Simulation technologies

A guide to the nuances of BAS, helping you stay one step ahead of cyber criminals

Download now


Network & Internet

BT unveils barrage of new business services

9 Oct 2019

Most Popular

mergers and acquisitions

Xerox to nominate directors to HP's board – reports

22 Jan 2020
operating systems

17 Windows 10 problems - and how to fix them

13 Jan 2020
public sector

UK gov launches £300,000 SEN EdTech initiative

22 Jan 2020
web browser

What is HTTP error 503 and how do you fix it?

7 Jan 2020